A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...

White matter alterations within the brain are associated with cognitive impairment among individuals with and without major ...

Depression is a serious mental health condition affecting millions of people worldwide, particularly middle-aged and older ...

Sleep problems may be one of the first symptoms of major depressive disorder -- a serious, but treatable mental health problem, more commonly known as depression. Not only a symptom of depression ...

Depression, sometimes called major depressive disorder, can hurt your ability to think through even simple daily tasks. Doctors call this decline in thinking skills "cognitive impairment." ...

People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

There is limited published data at higher doses and none in the treatment of Major Depressive Disorder (MDD). Methods This open-label, pilot study was designed to investigate the efficacy ...

From 2017 to 2021, pediatric depression and anxiety rates increased by 55.6% and 31.1%, respectively. Rates were higher ...

For decades, depression has been ascribed to chemical deficiencies in the brain. New evidence suggests inflammation may cause ...

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...